Insights
Research notes, technical papers and perspectives.
Insights is Noviota’s working publication space — research notes, technical explanations, project updates and longer essays arising from our work in infectious disease, immunology, computational biology and biological engineering.
The objective is not to maintain a high-volume corporate blog. We publish when a piece of work, method or argument is worth making available, and we favour material that can remain useful beyond the week in which it appears. Topics fall broadly into Research Notes, Technical, Perspectives and Projects.
Beyond Spike: What GSK’s Two-Antigen Flu Vaccine Tells Us About Programmable Vaccine Design
GSK's mRNA flu vaccine is advancing to Phase III - and it targets both haemagglutinin and neuraminidase, not HA alone. We look at what that design choice reveals about the…
Read →Biological Representation Is Not a Data-Formatting Problem
Making biological information machine-readable is not the same as representing biology. As computation moves towards reasoning and design, what we preserve about mechanism, context, evidence and provenance becomes increasingly important.
Read →Noviota Is Part of JDGS Holdings
Noviota Limited is wholly owned by JDGS Holdings, a privately owned group building specialist businesses across life science, agriculture and technology. A short note on where Noviota sits within that…
Read →